Latest Alzinova News & Updates

See the latest news and media coverage for Alzinova. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Alzinova

Clinical-stage biopharmaceutical company developing Alzheimer’s disease vaccines

alzinova.com
Headquarters
Gothenburg, Sweden
Founded year
2011
Company type
Public company
Number of employees
5–10
Industry
Pharmaceuticals

Last updated

Latest news about Alzinova

In short: Alzinova advanced its Alzheimer’s vaccine ALZ-101 toward Phase 2 trials and secured funding through rights issues and warrant exercises.

Company announcements

Alzinova

Alzinova receives SEK 15.3M from 94.2% warrant exercise

The funds will advance ALZ-101 towards Phase II, progress partnership talks, and continue diagnostics development.

Unlock all announcements with a

Media coverage

Placera.se

Alzinova to raise SEK 51 million through pre-emptive issue

Finwire Today, 06:32 Share Research company Alzinova is to carry out a pre-emptive issue of units which will bring in approximately SEK 51 million before issue costs, according to a press release. The terms are...

FinanzNachrichten.de

Alzinova AB: Alzinova publishes interim report for the period January - March 2026

The Board of Directors and the Chief Executive Officer of Alzinova AB hereby present the interim report for the period January - March 2026. The...

Unlock all articles with a

Never miss news about Alzinova

Track Alzinova and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Alzinova competitors & trending companies

Browse news for competitors to Alzinova and other trending companies.